|
|
Article: France Biotech, in collaboration with Eurobiomed, is to organize its 5th Bioethics Forum on Friday, December 11th, at the Musee du Carre d'Art in Nimes.
- Article from:
- Biotech Week
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
France Biotech, the French association of life science businesses and their partners (www.france-biotech.org) announced that its 5th Bioethics Forum (organized in collaboration with the Eurobiomed cluster) will take place on Friday, December 11th, at the Musee du Carre d'Art venue in Nimes (see also France Biotech).
Today, new treatments rely primarily on the pharmaceutical development of new chemical or biological entities. Even though pharmaceutical industry R&D budgets continue to increase in both Europe and North America, the number of new therapeutics that reach the market has fallen well short of what could be expected of these levels of investment.
Related newspaper, magazine, and journal articles:
|
|
Article: Bioethics forum: www.bioethicsforum.org.(REPORT: ...
The Hastings Center Report;
September 1, 2007 ;
537 words
...Recent highlights: "Paying Attention to the Trees, Not the Forest" BY THEODORE FRIEDMANN We should not hold gene therapy to an unachievable standard of perfection, considering each new failure in the clinic to be a threat to the very concept of the therapy itself. "A Donor Kidney: The Gift of
|
|